Literature DB >> 16407838

Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.

S Semba1, F Trapasso, M Fabbri, K A McCorkell, S Volinia, T Druck, D Iliopoulos, Y Pekarsky, H Ishii, P N Garrison, L D Barnes, C M Croce, K Huebner.   

Abstract

The Fhit tumor suppressor binds and hydrolyses diadenosine polyphosphates and the Fhit-substrate complex has been proposed as a proapoptotic effector, as determined by infection of susceptible cancer cells with adenoviruses carrying wild-type fragile histidine triad (FHIT) or catalytic site mutants. The highly conserved Fhit tyrosine 114 (Y114), within the unstructured loop C-terminal of the catalytic site, can be phosphorylated by Src family tyrosine kinases, although endogenous phospho-Fhit is rarely detected. To explore the importance of Y114 and identify Fhit-mediated signaling events, wild-type and Y114 mutant FHIT-expressing adenoviruses were introduced into two human lung cancer cell lines. Caspase-dependent apoptosis was effectively induced only by wild-type but not Y114 mutant Fhit proteins. By expression profiling of FHIT versus mutant FHIT-infected cells, we found that survivin, an Inhibitor of Apoptosis Protein (IAP) family member, was significantly decreased by wild-type Fhit. In addition, Fhit inhibited activity of Akt, a key effector in the phosphatidylinositol 3-OH kinase (PI3K) pathway; loss of endogenous Fhit expression caused increased Akt activity in vitro and in vivo, and overexpression of constitutively active Akt inhibited Fhit-induced apoptosis. The results indicate that the Fhit Y114 residue plays a critical role in Fhit-induced apoptosis, occurring through inactivation of the PI3K-Akt-survivin signal pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16407838     DOI: 10.1038/sj.onc.1209323

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   8.756


  44 in total

Review 1.  Validating survivin as a cancer therapeutic target.

Authors:  Dario C Altieri
Journal:  Nat Rev Cancer       Date:  2003-01       Impact factor: 60.716

2.  Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms.

Authors:  Preston N Garrison; Angela K Robinson; Yuri Pekarsky; Carlo M Croce; Larry D Barnes
Journal:  Biochemistry       Date:  2005-04-26       Impact factor: 3.162

3.  The tumor spectrum in FHIT-deficient mice.

Authors:  N Zanesi; V Fidanza; L Y Fong; R Mancini; T Druck; M Valtieri; T Rüdiger; P A McCue; C M Croce; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

4.  High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.

Authors:  Hirotaka Kato; Shuho Semba; Upik A Miskad; Yasushi Seo; Masato Kasuga; Hiroshi Yokozaki
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

5.  Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.

Authors:  L Ji; B Fang; N Yen; K Fong; J D Minna; J A Roth
Journal:  Cancer Res       Date:  1999-07-15       Impact factor: 12.701

6.  Muir-Torre-like syndrome in Fhit-deficient mice.

Authors:  L Y Fong; V Fidanza; N Zanesi; L F Lock; L D Siracusa; R Mancini; Z Siprashvili; M Ottey; S E Martin; T Druck; P A McCue; C M Croce; K Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

7.  Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines.

Authors:  Cinzia Sevignani; George A Calin; Rossano Cesari; Manuela Sarti; Hideshi Ishii; Sai Yendamuri; Andrea Vecchione; Francesco Trapasso; Carlo M Croce
Journal:  Cancer Res       Date:  2003-03-15       Impact factor: 12.701

8.  Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma.

Authors:  Tamotsu Kuroki; Francesco Trapasso; Sai Yendamuri; Ayumi Matsuyama; Hansjuerg Alder; Masaki Mori; Carlo M Croce
Journal:  Cancer Res       Date:  2003-07-01       Impact factor: 12.701

9.  Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications.

Authors:  Constantine S Mitsiades; Nicholas Mitsiades; Vassiliki Poulaki; Robert Schlossman; Masaharu Akiyama; Dharminder Chauhan; Teru Hideshima; Steven P Treon; Nikhil C Munshi; Paul G Richardson; Kenneth C Anderson
Journal:  Oncogene       Date:  2002-08-22       Impact factor: 9.867

10.  Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades.

Authors:  Yiling Lu; Qinghua Yu; Jue Hui Liu; Jinyi Zhang; Hongwei Wang; Dimpy Koul; John S McMurray; Xianjun Fang; W K Alfred Yung; Kathy A Siminovitch; Gordon B Mills
Journal:  J Biol Chem       Date:  2003-07-17       Impact factor: 5.157

View more
  21 in total

1.  Crystallization and preliminary X-ray crystallographic analysis of SMU.412c protein from the caries pathogen Streptococcus mutans.

Authors:  Zhao Yang Ye; Qiao Ming Hou; Lan Fen Li; Xiao Dong Su
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2009-03-25

2.  The effects of Fhit on tumorigenesis after multi-exposure to low-dose radiation.

Authors:  Xiaoyan Yu; Lin Lu; Siyuan Wen; Ya Wang
Journal:  Int J Clin Exp Med       Date:  2009-11-22

3.  Predictive value of FHIT, p27, and pERK1/ERK2 in salivary gland carcinomas: a retrospective study.

Authors:  Mathias Fiedler; Patty Renner; Jürgen Schubert; Florian Weber; Arndt Hartmann; Heinrich Iro; Veronika Vielsmeier; Christopher Bohr; Michael Gerken; Torsten E Reichert; Tobias Ettl
Journal:  Clin Oral Investig       Date:  2019-01-23       Impact factor: 3.573

4.  Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.

Authors:  Daniel L Kiss; Catherine E Waters; Iman M Ouda; Joshua C Saldivar; Jenna R Karras; Zaynab A Amin; Seham Mahrous; Teresa Druck; Ralf A Bundschuh; Daniel R Schoenberg; Kay Huebner
Journal:  Biochim Biophys Acta Gene Regul Mech       Date:  2017-01-14       Impact factor: 4.490

5.  FHIT-proteasome degradation caused by mitogenic stimulation of the EGF receptor family in cancer cells.

Authors:  Francesca Bianchi; Alessandra Magnifico; Clelia Olgiati; Nicola Zanesi; Yuri Pekarsky; Elda Tagliabue; Carlo Maria Croce; Sylvie Ménard; Manuela Campiglio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-01       Impact factor: 11.205

Review 6.  Src family kinases and paclitaxel sensitivity.

Authors:  Xiao-Feng Le; Robert C Bast
Journal:  Cancer Biol Ther       Date:  2011-08-15       Impact factor: 4.742

Review 7.  Survivin as a global target of intrinsic tumor suppression networks.

Authors:  Minakshi Guha; Dario C Altieri
Journal:  Cell Cycle       Date:  2009-09-07       Impact factor: 4.534

Review 8.  Fhit tumor suppressor: guardian of the preneoplastic genome.

Authors:  Flavia Pichiorri; Tiziana Palumbo; Sung-Suk Suh; Hiroshi Okamura; Francesco Trapasso; Hideshi Ishii; Kay Huebner; Carlo M Croce
Journal:  Future Oncol       Date:  2008-12       Impact factor: 3.404

9.  The tumor suppressor Fhit acts as a repressor of beta-catenin transcriptional activity.

Authors:  Jörg Weiske; Kai Frederik Albring; Otmar Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2007-12-10       Impact factor: 11.205

10.  Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions.

Authors:  Flavia Pichiorri; Hiroshi Okumura; Tatsuya Nakamura; Preston N Garrison; Pierluigi Gasparini; Sung-Suk Suh; Teresa Druck; Kelly A McCorkell; Larry D Barnes; Carlo M Croce; Kay Huebner
Journal:  J Biol Chem       Date:  2008-11-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.